The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
36 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The University of Melbourne is a research university that provides graduate, postgraduate, and research degrees. The university offers services in various fields that include arts, engineering, business and economics, architecture, building and planning, land and environment, medical, dentistry, information and technology, education, and health science, law, veterinary science, among others. It also provides awareness and management services to the society in the field of research and teaching services. The University of Melbournes health services comprise contraception, sexually transmitted infections, women's health, men's health, and others.

The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH117239D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
The University of Melbourne, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
The University of Melbourne, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
The University of Melbourne, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
The University of Melbourne, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
The University of Melbourne, Medical Devices Deals, 2010 to YTD 201691
The University of Melbourne, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
The University of Melbourne, Pharmaceuticals &Healthcare, Deal Details1221
  Venture Financing121
    Hatchtech Raises US$12 Million In Venture Financing122
    Hatchtech Raises US$6.3 Million In Venture Financing142
    Hatchtech Raises US$6.3 Million In Venture Financing162
  Partnerships181
    University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases181
    Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS191
    International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health201
    Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research211
    Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines221
    Janssen-Cilag Enters Into Research Agreement With University of Melbourne231
    Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health242
    Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre261
    ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research271
    Western Health Forms Joint Venture With Peter MacCallum Cancer Centre281
    AB SCIEX Enters Into Co-Development Agreement With University Of Melbourne291
    Vitrolife Enters Into Collaboration Agreement With University of Melbourne301
  Licensing Agreements311
    TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research312
The University of Melbourne - Key Competitors331
Key Employees341
Locations And Subsidiaries351
  Head Office351
  Other Locations &Subsidiaries351
Appendix361
  Methodology361
  About GlobalData361
  Contact Us361
  Disclaimer361

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-University-of-Melbourne-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7722>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-University-of-Melbourne-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7722>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research